万泽股份涨7.92%，股价创历史新高

Core Viewpoint - Wanzhou Co., Ltd. has reached a historical high in stock price, with a significant increase of 7.92% as of 9:42, reflecting strong market performance in the pharmaceutical and biotechnology sector [2] Company Summary - Wanzhou Co., Ltd. stock price is reported at 20.30 yuan, with a trading volume of 16.65 million shares and a transaction value of 337 million yuan, resulting in a turnover rate of 3.33% [2] - The latest total market capitalization of Wanzhou Co., Ltd. is 10.338 billion yuan, with a circulating market value of 10.149 billion yuan [2] - The company reported a revenue of 941 million yuan for the first three quarters, representing a year-on-year growth of 21.00% [2] - The net profit for the same period was 170 million yuan, showing a year-on-year increase of 22.45% [2] - Basic earnings per share are recorded at 0.3402 yuan, with a weighted average return on equity of 11.58% [2] Industry Summary - The pharmaceutical and biotechnology industry is currently experiencing an overall decline of 0.37%, with 89 stocks rising, including Wanzhou Co., Ltd. [2] - The top gainers in the industry include Hongyuan Pharmaceutical and Wanzhou Co., Ltd., with respective increases of 9.49% and 7.92% [2] - A total of 396 stocks in the industry have declined, with the largest drops seen in companies like Sunflower and Shutaishen, with declines of 7.00% and 6.64% respectively [2] - As of November 5, the margin trading balance for Wanzhou Co., Ltd. is 382 million yuan, with a financing balance of the same amount, reflecting a decrease of 87.62 million yuan over the past 10 days, a decline of 18.68% [2]